ConductScience.org, home

Paper42547263

Efficient discovery of an agonistic anti-OX40 nanobody by epitope-directed approach to address enrichment-driven epitope bias.

Iemura T and 10 others. J Immunother Cancer, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Efficient discovery of an agonistic anti-OX40 nanobody by epitope-directed approach to address enrichment-driven epitope bias. Papers, record 42547263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42547263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficient discovery of an agonistic anti-OX40 nanobody by epitope-directed approach to address enrichment-driven epitope bias.
PubMed
Journal
J Immunother Cancer
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iemura TTomoki
2Kitawaki TToshiohttps://orcid.org/0000-0002-6373-3442
3Maeda RRyota
4Mitsuyoshi TTakaya
5Nagata KKayoko
6Yamazaki HHiroyuki
7Shirakawa KKotaro
8Kobayashi NNaohiro
9Nagata TTakashihttps://orcid.org/0000-0002-3733-2709
10Imura AAkihiro
11Takaori-Kondo AAkifumi

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, OX40Major topic
Single-Domain AntibodiesMajor topic
EpitopesMajor topic
Animals
Humans
Mice
Epitope Mapping
Female
Immunotherapy

Source PubMed

Download CSV of topics

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138653243Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors.Cell Chem Biol2024https://conductscience.org/library/papers/38653243PubMed
240535010On the origin of non-specific binders isolated in the selection of phage display peptide libraries.Front Microbiol2025https://conductscience.org/library/papers/40535010PubMed
38520220NMRPipe: a multidimensional spectral processing system based on UNIX pipes.J Biomol NMR1995https://conductscience.org/library/papers/8520220PubMed
432816951Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors.Clin Cancer Res2020https://conductscience.org/library/papers/32816951PubMed
529985974Noise peak filtering in multi-dimensional NMR spectra using convolutional neural networks.Bioinformatics2018https://conductscience.org/library/papers/29985974PubMed
641041320Generation of novel human anti-OX-40 mAbs endowed with different biological properties as tools for cancer therapy.Front Immunol2025https://conductscience.org/library/papers/41041320PubMed
78642328The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells.J Exp Med1996https://conductscience.org/library/papers/8642328PubMed
825484045Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction.MAbs2014https://conductscience.org/library/papers/25484045PubMed
936316061First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors.J Immunother Cancer2022https://conductscience.org/library/papers/36316061PubMed
1035794202A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron.Commun Biol2022https://conductscience.org/library/papers/35794202PubMed
1125801209Combined automated NOE assignment and structure calculation with CYANA.J Biomol NMR2015https://conductscience.org/library/papers/25801209PubMed
1218490723Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival.J Immunol2008https://conductscience.org/library/papers/18490723PubMed
1322911360NMR View: A computer program for the visualization and analysis of NMR data.J Biomol NMR1994https://conductscience.org/library/papers/22911360PubMed
1433148673OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors.Clin Cancer Res2021https://conductscience.org/library/papers/33148673PubMed
1536927527First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1).J Immunother Cancer2023https://conductscience.org/library/papers/36927527PubMed
1640404202INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering.J Immunother Cancer2025https://conductscience.org/library/papers/40404202PubMed
1735699599First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors.Clin Cancer Res2022https://conductscience.org/library/papers/35699599PubMed
1819548092TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts.J Biomol NMR2009https://conductscience.org/library/papers/19548092PubMed
192180570Amplified and rearranged bcl-2 gene in two lymphoma cell lines, FL-218 and FL-318, carrying a 14;18 translocation.Cancer Res1990https://conductscience.org/library/papers/2180570PubMed
2020307208Control of immunity by the TNFR-related molecule OX40 (CD134).Annu Rev Immunol2010https://conductscience.org/library/papers/20307208PubMed

See all 57 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42547263

GET https://conductscience.org/api/papers/v1/42547263/references?page=2